FDA Clearance Tracker · P890027
NUCLEUS 22 CHANNEL COCHLEAR IMPLANT SYS /CHILDREN
Last checked: Nov 20, 2026Latest source record: Jun 27, 1990 (this decision)Source: openFDAMethods & limitations
Decided
Jun 27, 1990
Approved
Time to decision
408 days
Received May 15, 1989. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P890027
- Device name
- NUCLEUS 22 CHANNEL COCHLEAR IMPLANT SYS /CHILDREN
- Applicant
- Cochlear Americas
- Applicant location
- Lone Tree, CO
- Received
- May 15, 1989
- Decided
- Jun 27, 1990
- Decision
- Approved
- Supplements
- 65 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Implant, cochlear (MCM)
- Device class
- Class III
- Specialty
- Otolaryngology (ENT)
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MCM. The earliest in FDA's data is P830069, decided Nov 26, 1984.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Cochlear Americas
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K260902 · Decided Jul 10, 2026 · 114 days after receipt
Device type: Active Implantable Bone Conduction Hearing System (PFO) · Otolaryngology (ENT)
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.